Skip to content

Study in southern Mexico reports that DOTS programme can reduce the prevalence of drug resistant TB

HIV causes metabolic disturbances in the absence of antiretroviral therapy

Starting HAART with a CD4 cell count below 100 cells/mm3 a risk factor for IRIS, study finds

US approves new hepatitis B drug, entecavir (Baraclude)

‘ABC’ prevention is becoming ‘AB’ in Uganda, thanks to US influence against condom use, says report

Testing HIV-positive women for HPV can help predict risk of precancerous cervical changes

HIV-positive cocaine users have higher rates of coronary calcification

Revisions to India’s patent law could affect future supply of affordable generic antiretrovirals

Argentinian generic indinavir compares well with Crixivan